Author: Jane Edwards|| Date Published: December 28, 2016
Four companies have won spots on a potential 10-year, $159 million contract to provide preclinical drug development support services for the National Institute of Allergy and Infectious Diseases.
The multiple-award, indefinite-delivery/indefinite-quantity contract covers the development of manufacturing processes and analytical test procedures, regulatory services, manufacturing and product characterization in support of the development of biopharmaceutical drug candidates for infectious diseases, the National Institutes of Health said in a FedBizOpps notice.
Lockheed Martin has received a $249 million indefinite-delivery/indefinite-quantity contract from the U.S. Navy to support the Surface Electronic Warfare Improvement Program,…
Qualis, InTrack Radar Technologies and Tektonux have merged to form a single company focused on modernizing missile defense, space domain awareness, integrated fires…
Four companies have won spots on a potential 10-year, $159 million contract to provide preclinical drug development support services for the National Institute of Allergy and Infectious Diseases.
